Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kestra Medical TechnologiesKMTS -4.71%12 3-Year Revenue Growth Rate is 66.00% as of Apr. 2026, which is at its 10-year median of 66.00. GuruFocus rates KMTS with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Kestra Medical Technologies ranks better than 97.1% on this metric.
During the past 12 months, Kestra Medical Technologies's average Revenue per Share Growth Rate was -27.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 66.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 4 years, the highest 3-Year average Revenue per Share Growth Rate of Kestra Medical Technologies was 66.00% per year. The lowest was 66.00% per year. And the median was 66.00% per year.
Kestra Medical Technologies (NAS:KMTS) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Kestra Medical Technologies 3-Year Revenue Growth Rate Related Terms
KMTS vs AZTA, BLFS, LMAT: 3-Year Revenue Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Kestra Medical Technologies's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kestra Medical Technologies 3-Year Revenue Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kestra Medical Technologies's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Kestra Medical Technologies's 3-Year Revenue Growth Rate falls into.
Kestra Medical Technologies 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 66.00% mean?
Kestra Medical Technologies (KMTS) has a 3-Year Revenue Growth Rate of 66.00% as of Apr. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Kestra Medical Technologies and its competitors. This is near median its historical median of 66.00. Over the past decade, Kestra Medical Technologies' 3-Year Revenue Growth Rate has ranged from 66.00 to 66.00. According to the industry distribution chart, Kestra Medical Technologies ranks #22 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 2.9%.
Is Kestra Medical Technologies' 3-Year Revenue Growth Rate too high?
Kestra Medical Technologies' current 3-Year Revenue Growth Rate of 66.00% is near median its 10-year median of 66.00. Over the past 10 years, this metric has ranged from a low of 66.00 to a high of 66.00. The Medical Devices & Instruments industry median 3-Year Revenue Growth Rate is 3.80. Kestra Medical Technologies' value of 66.00% is 1636.8% above this industry median. Based on the distribution chart, Kestra Medical Technologies ranks #22 out of 759 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kestra Medical Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' 3-Year Revenue Growth Rate compare to AZTA and BLFS?
According to the Medical Devices & Instruments industry distribution chart, Kestra Medical Technologies ranks #22 out of 759 companies for 3-Year Revenue Growth Rate. This places Kestra Medical Technologies in the top 3% of its industry — outperforming the majority of peers. The industry median 3-Year Revenue Growth Rate is 3.80. Kestra Medical Technologies' value of 66.00% is 1636.8% above this benchmark. Historically, Kestra Medical Technologies' own 3-Year Revenue Growth Rate has ranged from 66.00 to 66.00 over the past decade. While the company's 10-year median is 66.00 vs. the industry median of 3.80, Kestra Medical Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Revenue Growth Rate among Medical Devices & Instruments companies is 3.80, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kestra Medical Technologies's current 3-Year Revenue Growth Rate of 66.00% is 1636.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Kestra Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Revenue Growth Rate is 3.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kestra Medical Technologies's current 3-Year Revenue Growth Rate is 66.00%, which is near median its own 10-year median of 66.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current 3-Year Revenue Growth Rate of 66.00%. The current 3-Year Revenue Growth Rate is 66.00%, which is near median its 10-year median of 66.00 and 1636.8% above the Medical Devices & Instruments industry median of 3.80. Kestra Medical Technologies' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current 3-Year Revenue Growth Rate is 66.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
12GF Score
Get the complete analysis for KMTS
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KMTS has been successfully added to your 
